ABVC (STOCKS)
ABVC BioPharma, Inc. Common Stock
$1.380000
-0.050000 (-3.50%)
Prev close: $1.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Uttam Yashwant Patil
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $36.38M
- Employees
- 19
- P/E (TTM)
- -3.72
- P/B (TTM)
- 3.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$-0.06 | $0.00 | +0.0000 | +0.00% |
|
Jun 2023 (Q2)
|
$-0.68 | $-0.06 | -0.6188 | -1,011.11% |
|
Mar 2023 (Q1)
|
$-0.60 | $-0.51 | -0.0900 | -17.65% |
|
Dec 2022 (Q4)
|
$-1.50 | $-1.53 | +0.0300 | +1.96% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$1.20M |
| Operating Expenses | $7.15M |
| Selling, General, and Administrative Expenses | $2.89M |
| Research and Development | $121.09K |
| Other Operating Expenses | $4.14M |
| Operating Income/Loss | -$7.15M |
| Income/Loss Before Equity Method Investments | -$7.55M |
| Income/Loss From Continuing Operations After Tax | -$8.38M |
| Income/Loss From Continuing Operations Before Tax | -$8.35M |
| Income/Loss From Equity Method Investments | -$803.01K |
| Income Tax Expense/Benefit | $24.15K |
| Income Tax Expense/Benefit, Current | $24.15K |
| Net Income/Loss | -$8.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$468.41K |
| Net Income/Loss Attributable To Parent | -$7.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.39 |
| Diluted Earnings Per Share | -$0.39 |
| Basic Average Shares | 20,108,944 |
| Diluted Average Shares | 20,108,944 |
| Assets | $21.06M |
| Current Assets | $2.50M |
| Noncurrent Assets | $18.56M |
| Fixed Assets | $12.84M |
| Non-current Prepaid Expenses | $1.12M |
| Other Non-current Assets | $4.60M |
| Liabilities | $7.76M |
| Current Liabilities | $6.16M |
| Wages | $86.74K |
| Other Current Liabilities | $6.08M |
| Noncurrent Liabilities | $1.60M |
| Equity | $13.30M |
| Equity Attributable To Noncontrolling Interest | $2.19M |
| Equity Attributable To Parent | $11.11M |
| Liabilities And Equity | $21.06M |
| Net Cash Flow From Operating Activities | -$2.99M |
| Net Cash Flow From Operating Activities, Continuing | -$2.99M |
| Net Cash Flow From Investing Activities | -$1.21M |
| Net Cash Flow From Investing Activities, Continuing | -$1.21M |
| Net Cash Flow From Financing Activities | $4.64M |
| Net Cash Flow From Financing Activities, Continuing | $4.64M |
| Exchange Gains/Losses | $20.26K |
| Net Cash Flow | $463.17K |
| Net Cash Flow, Continuing | $442.91K |
| Comprehensive Income/Loss | -$7.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.87M |
| Other Comprehensive Income/Loss | $510.34K |